Effect of sympathetic denervation on the rate of protein synthesis in rat skeletal muscle

American Journal of Physiology - Endocrinology and Metabolism

Volumn 286, Issue 4 49-4, 2004, Pages

  Navegantes, Luiz Carlos C ^a   Resano, Neusa M Z ^a   Baviera, Amanda M ^a   Migliorini, Renato H ^a   Kettelhut, Isis C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Catecholamines; Clenbuterol; Isoproterenol; Surgical and chemical sympathectomy

Indexed keywords

ADRENALIN; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CLENBUTEROL; GUANETHIDINE; ISOPRENALINE; PROTEIN; TYROSINE;

ADRENAL MEDULLECTOMY; ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DENERVATION; HINDLIMB; HORMONE DEFICIENCY; MALE; NONHUMAN; NUTRITIONAL DEFICIENCY; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SKELETAL MUSCLE; SOLEUS MUSCLE; SPINAL GANGLION; SYMPATHECTOMY; SYMPATHETIC NERVE; SYMPATHETIC TRUNK; WEIGHT GAIN;

ADRENAL MEDULLA; ADRENERGIC AGENTS; ADRENERGIC BETA-AGONISTS; ANIMALS; BLOOD GLUCOSE; CATECHOLAMINES; CLENBUTEROL; CORTICOSTERONE; FASTING; GUANETHIDINE; ISOPROTERENOL; KINETICS; MALE; MUSCLE PROTEINS; MUSCLE, SKELETAL; RATS; RATS, WISTAR; SYMPATHECTOMY; TYROSINE;

EID: 1642286149     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00371.2003     Document Type: Article

References (37)

1. Babij P and Booth FW. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle. Am J Physiol Cell Physiol 254: C657-C660, 1988.
2. Baron R, Janig W, and Kollmann W. Sympathetic and afferent somata projecting in hindlimb nerves and the anatomical organization of the lumbar sympathetic nervous system of the rat. J Comp Neurol 275: 460-468, 1988.
3. Béchet DM, Listrat A, Deval C, Ferrara M, and Quirke JF. Cimaterol reduces cathepsin activities but has no anabolic effect in cultured myotubes. Am J Physiol Endocrinol Metab 259: E822-E827, 1990.
4. Byrem T, Beermann DH, and Robinson TF. The beta-agonist cimaterol directly enhances chronic protein accretion in skeletal muscle. J Anim Sci 76: 988-998, 1998.
5. Claeys MC, Mulvaney DR, McCarthy FD, Gore MT, Marple DN, and Sartin JL. Skeletal muscle protein synthesis and growth-hormone secretion in young lambs treated with clenbuterol. J Anim Sci 67: 2245-2254, 1989.
6. De Feo P. Hormonal regulation of human protein metabolism. Eur J Endocrinol 135: 7-18, 1996.
7. Fagius F, Niklasson F, and Berne C. Sympathetic outflow in human muscle nerves increases during hypoglycemia. Diabetes 35: 1124-1129, 1986.
8. Fulks RM, Li JB, and Goldberg AL. Effects of insulin, glucose, and amino acids on protein turnover in rat diaphragm. J Biol Chem 250: 290-298, 1975.
9. Garófalo MAR, Kettelhut IC, Roselino JES, and Migliorini RH. Effect of acute cold exposure on norepinephrine turnover rates in rat white adipose tissue. J Auton Nerv Syst 60: 206-208, 1996.
10. Glaubiger G, Tsai BS, Lefkowitz RJ, Weiss B, and Johnson E Jr. Chronic guanethidine treatment increases cardiac β-adrenergic receptors. Nature 273: 240-242, 1978.
11. Helferich WG, Jump DB, Anderson DB, Skjaerlund DM, Merkel RA, and Bergen WG. Skeletal muscle alpha-actin synthesis is increased pretranslationally in pigs fed the phenethanolamine ractopamine. Endocrinology 126: 3096-3100, 1990.
12. Herndon DN, Hart DW, Wolf SE, Chinkes DL, and Wolfe RR. Reversal of catabolism by beta-blockade after several burns. N Engl J Med 345: 1223-1229, 2001.
13. Hesketh JE, Campbell GP, Lobley GE, Maltin CA, Acamovic F, and Palmer RM. Stimulation of actin and myosin synthesis in rat gastrocnemius muscle by clenbuterol: evidence for translational control. Comp Biochem Physiol 102C: 23-27, 1992.
14. Kim YS and Sainz RD. β-Adrenergic agonists and hypertrophy of skeletal muscles. Life Sci 50: 397-407, 1991.
15. Kim YS, Sainz RD, Summers RJ, and Molenaar P. Cimaterol reduces β-adrenergic receptor density in rat skeletal muscles. J Anim Sci 70: 115-122, 1992.
16. Lee BY, Ostrander LE, Thoden WR, and Madden JL. Effect of lumbar sympathectomy on muscle blood flow: distribution of perfusion measured by hydrogen clearance in skeletal muscle. J Rehabil Res Dev 24: 1-8, 1987.
17. Maggs DG, Jacob R, Rife F, Caprio S, Tamborlane WV, and Sherwin RS. Effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue. Diabetes 46: 70-76, 1997.
18. 2-adrenergic agonist clenbuterol on growth and protein metabolism in rat muscle cell cultures. J Anim Sci 70: 3014-3023, 1992.
19. Mersmann HJ. Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. J Anim Sci 76: 160-172, 1998.
20. Navegantes LCC, Migliorini RH, and Kettelhut IC. Adrenergic control of protein metabolism in skeletal muscle. Curr Opin Clin Nutr Metab Care 5: 281-286, 2002.
21. Navegantes LCC, Resano NMZ, Migliorini RH, and Kettelhut IC. Effect of guanethidine-induced adrenergic blockade on the different proteolytic systems in rat skeletal muscle. Am J Physiol Endocrinol Metab 277: E883-E889, 1999.
22. Navegantes LCC, Resano NMZ, Migliorini RH, and Kettelhut IC. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab 279: E663-E668, 2000.
23. 2-adrenoceptors and cAMP. Am J Physiol Endocrinol Metab 281: E449-E454, 2001.
24. Nutting DF. Anabolic effects of catecholamines in diaphragm muscle from hypophysectomized rats. Endocrinology 110: 307-317, 1982.
25. Palmer GC. Increased cyclic AMP response to norepinephrine in the rat brain following 6-hydroxydopamine. Neuropharmacology 11: 145-149, 1972.
26. Pascual M, Del Barrio AS, Portillo MP, Martinez JA, and Larralde J. Tissue protein turnover in animals treated with the mixed β-agonist metaproterenol: influence of dose, route and pattern of administration. Biochimie 75: 879-883, 1993.
27. Pepato MT, Migliorini RH, Goldberg AL, and Kettelhut IC. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 271: E340-E347, 1996.
28. Reeds PJ, Hay SM, Dorwood PM, and Palmer RM. Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis. Br J Nutr 56: 249-258, 1986.
29. Rooyackers OE and Nair KS. Hormonal regulation of human muscle protein metabolism. Annu Rev Nutr 17: 457-485, 1997.
30. 2-adrenoceptor agonist clenbuterol. Br J Pharmacol 90: 601-607, 1987.
31. Scharff R and Wool IG. Effect of diabetes on the concentration of amino acids in plasma and heart muscle of rats. Biochem J 99: 173-178, 1966.
32. Takahashi A, Ikarashi Y, Ishimaru H, and Maruyama Y. Compensation between sympathetic nerves and adrenalmedullary activity: effects of adrenodemedullation and sympathectomy on catecholamine turnover. Life Sci 53: 1567-1572, 1993.
33. Tischler ME, Desautels M, and Goldberg AL. Does leucine, leucyl-tRNA or some metabolic of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 257: 1613-1621, 1982.
34. Vollmer RR, Balcita-Pedicino JJ, Debnam AJ, and Edwards DJ. Adrenal medullary catecholamine secretion patterns in rats evoked by reflex and direct neural stimulation. Clin Exp Hypertens 22: 705-715, 2000.
35. Waalkes TP and Udenfriend S. A fluorometric method for the estimation of tyrosine in plasma and tissues. J Lab Clin Med 50: 733-736, 1957.
36. Winder WW, MacLean PS, Chandler SL, Huang W, and Mills RH. Role of epinephrine during insulin-induced hypoglycemia in fasted rats. J Appl Physiol 77: 270-276, 1994.
37. 2-agonist, retards atrophy in denervated muscles. Am J Physiol Endocrinol Metab 252: E152-E155, 1987.